Principio attivo ATC Farmaco Aciclovir Aciclovir J05AB01 J05AB01 ACICLIN ACICLOVIR Aciclovir J05AB01 ACICLOVIR Aciclovir J05AB01 ACICLOVIR Confezione 8% SOSPENSIONE ORALE…

1. TSE:4568 Reference Data(Consolidated Financial Results for Q1 FY2012) July 31, 2012 Daiichi Sankyo Co., Ltd. http://www.daiichisankyo.com 2. MEMO (This page is intentionally…

Initiating Coverage   Ranbaxy Laboratories  Set to get back lost sheen   Ranbaxy after witnessing the worst time is now set to get back the lost sheen. …

1. Journal ClubDr Awadhesh Kumar Sharma 2. Intracoronary Compared with IntravenousBolus Abciximab ApplicationDuring PrimaryPercutaneous Coronary InterventionCardiac Magnetic…

1. 2011Luo, Sun, and Wang 37 ARTIC LE S Emerging Economy Copycats: Capability, Environment, and Strategy by Yadong Luo, Jinyun Sun, and Stephanie Lu Wang Executive Overview…

1. Broad Opportunities in Pharmacy Career Dr. Bhaswat S. Chakraborty Sr. VP & Chair, Science Core Committee, R&D Cadila Pharmaceuticals Ltd. Presented at Nirma University…

1. Pharmaceutical Industr y &Clinical Research: Basic Intro Dr. Bhaswat S. Chakraborty 2. Global Pharmaceutical Market• The global pharmaceutical market research has…

Slide 1 Slide 2 National Experts in Cardiovascular Medicine Illuminate and Debate Illuminate and Debate New Frontiers in Atrial Fibrillation Emerging Perspectives in Thrombosis…

Slide 1 Slide 2 The Evolving Science and Controversial Landscape of Antiplatelet Therapy in the Catheterization Laboratory Mechanisms Mortality Therapeutics PROGRAM CO-CHAIRMAN…

Slide 1 Slide 2 Stroke Prevention in Atrial Fibrillation Evidence- and Guideline-Based Strategies for Optimizing Clinical Outcomes and Anticoagulation-Based Management for…